Gut–Brain Axis Modulation by Short‐Chain Fatty Acids Exerts Disease‐Modifying Effects in a Murine Model of Drug‐Resistant Epilepsy
Annals of Neurology · 2026-09 · 100 (3) · 613-627
DOI: 10.1002/ana.78283 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 20.06.2026. Verfasst von Akash A Bera und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Acute Brain and Cardiovascular Injury, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. Hauptthemen laut MEDLINE: Fatty Acids, Volatile, Brain-Gut Axis, Drug Resistant Epilepsy, Gastrointestinal Microbiome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
Drug‐resistant epilepsy (DRE) remains a clinical challenge, as therapies modifying disease trajectory are lacking. Increasing evidence implicates gut microbiota dysbiosis in epilepsy pathophysiology, with short‐chain fatty acids (SCFAs) emerging as key microbial metabolites with neuroprotective and anti‐inflammatory properties. Clinical studies show that people with DRE exhibit gut microbiota alterations that may impair fecal SCFAs production. Here, we investigated whether supplementation of SCFAs confers disease‐modifying effects in a preclinical model of DRE.
Methods
Adult male mice were subjected to status epilepticus (SE) and subsequently treated with a balanced mixture of acetate, propionate, and butyrate, or vehicle. Seizure frequency and temporal progression were monitored for 70 days by electroencephalography (EEG). At the study end point, cognitive performance, brain and gut histopathology, and neuroinflammation were assessed, together with metabolomic profiling of feces and blood. Brain SCFA levels and receptor expression were also analyzed in mice and in brain tissue from individuals with DRE.
Results
SCFA supplementation reduced the proportion of mice exhibiting a progressive phenotype and decreased the overall progression index (PI) 3‐fold, without significantly altering overall daily seizure frequency. Treatment reduced seizure clustering, improved cognitive deficits, restored hippocampal and intestinal alterations, and partially normalized cerebral SCFAs levels. Metabolomic profiling in epileptic mice and analysis of human epilepsy brain tissue support a mechanistic contribution of gut‐brain axis dysfunction to disease progression.
Interpretation
These findings identify SCFAs supplementation as a therapeutic strategy capable of modifying disease trajectory in experimental DRE, with clear translational relevance. ANN NEUROL 2026;100:613–627
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Acute Brain and Cardiovascular Injury, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
- Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal, and Child Health, University of Genova, Genoa, Italy.
- University Hospital Würzburg, Würzburg, Germany.
- Core Facility for Omics Sciences, IRCCS Istituto Giannina Gaslini, Genova, Italy.
- Department of (Neuro)Pathology, Amsterdam UMC Location University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.
- Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
ORCID-Profile: Akash A Bera, Rossella Di Sapia, Greta Volpedo, Eray Sahin, Andrea Petretto, Chiara Lavarello, James D Mills, Ilaria Craparotta, Eleonora Aronica, Antonella Riva, Pasquale Striano, Annamaria Vezzani, Teresa Ravizza
Zitieren
APA
Bera, A. A., Sapia, R. D., Volpedo, G., Anand, S., Sahin, E., Baldassarre, P., Buffelli, F., Petretto, A., Lavarello, C., Mills, J. D., Cattaneo, G., Craparotta, I., Aronica, E., Riva, A., Striano, P., Vezzani, A., & Ravizza, T. (2026). Gut–Brain Axis Modulation by Short‐Chain Fatty Acids Exerts Disease‐Modifying Effects in a Murine Model of Drug‐Resistant Epilepsy. Annals of Neurology, 100(3), 613-627. https://doi.org/10.1002/ana.78283
Vancouver
Bera AA, Sapia RD, Volpedo G, Anand S, Sahin E, Baldassarre P, et al. Gut–Brain Axis Modulation by Short‐Chain Fatty Acids Exerts Disease‐Modifying Effects in a Murine Model of Drug‐Resistant Epilepsy. Annals of Neurology. 2026;100(3):613-627. doi:10.1002/ana.78283
BibTeX
@article{Bera2026,
author = {Bera, Akash A and Sapia, Rossella Di and Volpedo, Greta and Anand, Sneha and Sahin, Eray and Baldassarre, Pasquale and Buffelli, Francesca and Petretto, Andrea and Lavarello, Chiara and Mills, James D and Cattaneo, Gabriele and Craparotta, Ilaria and Aronica, Eleonora and Riva, Antonella and Striano, Pasquale and Vezzani, Annamaria and Ravizza, Teresa},
title = {Gut–Brain Axis Modulation by Short‐Chain Fatty Acids Exerts Disease‐Modifying Effects in a Murine Model of Drug‐Resistant Epilepsy},
journal = {Annals of Neurology},
year = {2026},
volume = {100},
number = {3},
pages = {613--627},
doi = {10.1002/ana.78283}
}
EUVIMED